GERD
Conditions
Brief summary
Evaluation of the Gatekeeper System in the treatment of patients with Gastroesophageal Reflux Disease (GERD) who already have been treated under study protocols Endo 2000-03 and Endo 2000-04
Interventions
Sponsors
Eligibility
Inclusion criteria
* Subjects must have been part of the Endo 2000-03 or Endo 2000-04 clinical study * Subjects who have been informed of the nature of the long-term follow-up study and have agreed to its participation and provided Informed Consent
Exclusion criteria
* Underwent another endoscopic or surgical treatment for GERD (except re-intervention with Gatekeeper) * Developed other medical illness that may cause the subject to be non-compliant * Extensive Barrett's Esophagus (\>2 cm) * Unable or unwilling to cooperate with the study procedures
Countries
Switzerland, United States